Clinical Assessment of a HYDRAGLYDE ® Regimen
Conditions:   Refractive Errors;   Myopia;   Hypermetropia Interventions:   Device: Lotrafilcon B contact lenses with added wetting agent;   Device: Samfilcon A contact lenses;   Device: POLYQUAD/ALDOX-preserved contact lens solution with added wetting agent;   Device: Hydrogen peroxide-based contact lens solution with added wetting agent;   Device: Senofilcon  C contact lenses;   Device: Senofilcon A contact lenses;   Device: Comfilcon A contact lenses;   Device: Habitual Multi-Purpose Solution (HMPS) Sponsor:   Alcon, a Novartis Company Not yet recruiting - verified January 2017 (Sourc...
Source: ClinicalTrials.gov - January 18, 2017 Category: Research Source Type: clinical trials